From Wikipedia, the free encyclopedia
2C-I animation.gif
Preferred IUPAC name
  • 69587-11-7 N
3D model (JSmol)
  • Interactive image
  • ChEMBL338297 YesY
  • 8442670 YesY
ECHA InfoCard 100.217.507
PubChem CID
  • 10267191
  • S35362848V N
Molar mass 307.13 g·mol−1
Melting point 246 °C (475 °F; 519 K)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
N verify (what is YesYN ?)
Infobox references

2C-I is a psychedelic phenethylamine of the 2C family.[1] It was first synthesized by Alexander Shulgin and described in his 1991 book PiHKAL: A Chemical Love Story. The drug is used recreationally for its psychedelic and entactogenic effects and is sometimes confused for the analog 25I-NBOMe, nicknamed "Smiles," in the media.[2][3][4]

Recreational use

the drug 2C-I in powder form

In the early 2000s, 2C-I was sold in Dutch smart shops after the drug 2C-B was banned.[5]

According to the US Drug Enforcement Administration, 2C-I is taken orally or snorted in a powder form.[6]

Drug prohibition laws

European Union

In December 2003, the European Council issued a binding order compelling all EU member states to ban 2C-I within three months.[7]


As of October 31, 2016, 2C-I is a controlled substance (Schedule III) in Canada.[8]


2C-I is a schedule 9 prohibited substance in Australia under the Poisons Standard (October 2015).[9] A schedule 9 drug is outlined in the Poisons Act 1964 as "Substances which may be abused or misused, the manufacture, possession, sale or use of which should be prohibited by law except when required for medical or scientific research, or for analytical, teaching or training purposes with approval of the CEO."[10]


Sveriges riksdag added 2C-I to schedule I ("substances, plant materials and fungi which normally do not have medical use") as narcotics in Sweden as of Mar 16, 2004, published by Medical Products Agency in their regulation LVFS 2004:3 listed as 4-jodo-2,5-dimetoxifenetylamin (2C-I).[11]

United Kingdom

In the United Kingdom, 2C-I is controlled as a Class A substance.[7]

United States

As of July 9, 2012, in the United States 2C-I is a Schedule I substance under the Synthetic Drug Abuse Prevention Act of 2012, making possession, distribution and manufacture illegal.[7] A previous bill, introduced in March 2011, that would have done the same passed the House of Representatives, but was not passed by the Senate.[12]

Analogues and derivatives

See also


  1. ^ "Erowid Online Books : "PIHKAL" - #33 2C-I". 
  2. ^ "25I-NBOMe (2C-I-NBOMe): Fatalities / Deaths". 
  3. ^ Weiss, Piper (September 20, 2012). 2C-I or 'Smiles': The New Killer Drug Every Parent Should Know About. Yahoo! News
  4. ^ Mackin, Teresa (October 9, 2012). Dangerous synthetic drug making its way across the country. Archived October 31, 2012, at the Wayback Machine. WISH-TV
  5. ^ de Boer; et al. (May–June 1999). "More Data About the New Psychoactive Drug 2C-B" (PDF). Journal of Analytical Toxicology. 23 (3): 227–228. doi:10.1093/jat/23.3.227. PMID 10369336. Retrieved 16 August 2012. 
  6. ^ Reuters (March 20, 2011). Synthetic drug, subject of proposed bans, kill teen.
  7. ^ a b c "Erowid 2C-I Vault : Legal Status". 
  8. ^ Regulations Amending the Food and Drug Regulations (Part J — 2C-phenethylamines)
  9. ^ Poisons Standard October 2015
  10. ^ Poisons Act 1964
  11. ^ "Läkemedelsverkets författningssamling" (PDF) (in Swedish). 
  12. ^ "H.R. 1254 (112th): Synthetic Drug Control Act of 2011". GovTrack. Retrieved 30 September 2015. 

External links

  • Erowid 2C-I Vault
  • Una experiencia con 2C-I de los Shulgin (In Spanish)
  • 2C-I Entry in PiHKAL
  • 2C-I Entry in PiHKAL • info
Retrieved from "https://en.wikipedia.org/w/index.php?title=2C-I&oldid=806520482"
This content was retrieved from Wikipedia : http://en.wikipedia.org/wiki/2C-I
This page is based on the copyrighted Wikipedia article "2C-I"; it is used under the Creative Commons Attribution-ShareAlike 3.0 Unported License (CC-BY-SA). You may redistribute it, verbatim or modified, providing that you comply with the terms of the CC-BY-SA